Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis.

Toxicology and applied pharmacology 20140915

L-Leucine and L-isoleucine enhance growth of BBN-induced urothelial tumors in the rat bladder by modulating expression of amino acid transporters and tumorigenesis-associated genes.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20130901

Mitochondrial and liver oxidative stress alterations induced by N-butyl-N-(4-hydroxybutyl)nitrosamine: relevance for hepatotoxicity.

Journal of applied toxicology : JAT 20130601

Long-term treatment with L-isoleucine or L-leucine in AIN-93G diet has promoting effects on rat bladder carcinogenesis.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20121101

Angiogenesis inhibition by green propolis and the angiogenic effect of L-lysine on bladder cancer in rats.

Acta cirurgica brasileira 20120801

Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.

Cancer research 20120701

The role of the androgen receptor in the development and progression of bladder cancer.

Japanese journal of clinical oncology 20120701

Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.

Mutation research 20120218

Inorganic arsenic in drinking water accelerates N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tissue damage in mice.

Toxicology and applied pharmacology 20120215

The importance of integrin-linked kinase in the regulation of bladder cancer invasion.

International journal of cancer 20120201

Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer.

Cancer prevention research (Philadelphia, Pa.) 20120201

Chemoprevention with green propolis green propolis extracted in L-lysine versus carcinogenesis promotion with L-lysine in N-Butyl-N-[4-hydroxybutyl] nitrosamine (BBN) induced rat bladder cancer.

Acta cirurgica brasileira 20120201

Rictor-dependent AKT activation and inhibition of urothelial carcinoma by rapamycin.

Urologic oncology 20120101

Review: BBN as an urothelial carcinogen.

In vivo (Athens, Greece) 20120101

Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties.

International journal of molecular sciences 20120101

Stathmin is dispensable for tumor onset in mice.

PloS one 20120101

Medium-term multi-organ carcinogenesis bioassay of ethyl tertiary-butyl ether in rats.

Toxicology 20111118

Thioredoxin-interacting protein suppresses bladder carcinogenesis.

Carcinogenesis 20111001

Nicotinamide inhibits growth of carcinogen induced mouse bladder tumor and human bladder tumor xenograft through up-regulation of RUNX3 and p300.

The Journal of urology 20110601

The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma.

Anticancer research 20110601

Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.

Virchows Archiv : an international journal of pathology 20110501

Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: dose dependency and modulation of biomarkers.

Oncology reports 20110501

Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions.

Anticancer research 20110501

Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo.

Journal of ethnopharmacology 20110426

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

Diabetes care 20110401

Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development.

Oncogene 20110210

Inhibition of bladder tumour growth by sirolimus in an experimental carcinogenesis model.

BJU international 20110101

Protective Mechanism of KIOM-4 in Streptozotocin-Induced Pancreatic β-Cells Damage Is Involved in the Inhibition of Endoplasmic Reticulum Stress.

Evidence-based complementary and alternative medicine : eCAM 20110101

Inhibition of urinary bladder carcinogenesis by aqueous extract of sclerotia of Polyporus umbellatus fries and polyporus polysaccharide.

The American journal of Chinese medicine 20110101

Common fragile site tumor suppressor genes and corresponding mouse models of cancer.

Journal of biomedicine & biotechnology 20110101

Pathobiology and chemoprevention of bladder cancer.

Journal of oncology 20110101

Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model.

PloS one 20110101

The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats.

Cancer cell international 20110101

Folic acid supplementary reduce the incidence of adenocarcinoma in a mouse model of colorectal cancer: microarray gene expression profile.

Journal of experimental & clinical cancer research : CR 20110101

Two new cytotoxic candidaspongiolides from an indonesian sponge.

ISRN pharmaceutics 20110101

Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4.

International journal of cancer 20100901

Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer.

Cancer metastasis reviews 20100901

A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma.

World journal of urology 20100801

Green tea polyphenol suppresses tumor invasion and angiogenesis in N-butyl-(-4-hydroxybutyl) nitrosamine-induced bladder cancer.

Cancer epidemiology 20100601

Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice.

Journal of biochemistry 20100301

Potential effects of the herbicide Diuron on mammary and urinary bladder two-stage carcinogenesis in a female Swiss mouse model.

Archives of toxicology 20100201

Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor.

Urologic oncology 20100101

Rat medium-term multi-organ carcinogenesis bioassay of Agaricus blazei Murrill fruit-body extract.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20100101

Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.

Mediators of inflammation 20100101

Gene profiling of cyclosporin-enhanced transitional cell carcinoma in rat model.

Transplantation proceedings 20091201

Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers.

Cancer prevention research (Philadelphia, Pa.) 20091101

Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxygenase-2 inhibition as chemoprevention for rat bladder carcinogenesis.

Cancer biology & therapy 20090901

The effects of sirolimus on urothelial lesions chemically induced in ICR mice by BBN.

Anticancer research 20090801

Anti-tumor effect of cimetidine via inhibiting angiogenesis factors in N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse and rat bladder carcinogenesis.

Oncology reports 20090701

Bladder outlet obstruction accelerates bladder carcinogenesis.

BJU international 20090501

Identification of differently expressed genes in chemical carcinogen-induced rat bladder cancers.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20090401

Regulation of the prostaglandin pathway during development of invasive bladder cancer in mice.

Prostaglandins & other lipid mediators 20090101

Inhibitory effects of the aqueous extract of Magnolia officinalis on the responses of human urinary bladder cancer 5637 cells in vitro and mouse urinary bladder tumors induced by N-Butyl-N-(4-hydroxybutyl) nitrosamine in vivo.

Phytotherapy research : PTR 20090101

DNA cytometry and kinetics of rat urothelial lesions during chemical carcinogenesis.

Oncology reports 20090101

Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.

International journal of cancer 20081115

Molecular credentialing of rodent bladder carcinogenesis models.

Neoplasia (New York, N.Y.) 20080801

Effect of cranberry juice concentrate on chemically-induced urinary bladder cancers.

Oncology reports 20080601

Possible carcinogenic risks of copper gluconate and their prevention by co-administered green tea catechins evaluated by a rat medium-term multi-organ carcinogenicity bioassay protocol.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20080501

Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.

Carcinogenesis 20080401

5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.

International journal of clinical oncology 20080401

Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.

International journal of cancer 20080315

Inhibition of urinary bladder carcinogenesis by broccoli sprouts.

Cancer research 20080301

Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1.

BMC urology 20080101

Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.

Molecular cancer therapeutics 20071201

Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.

Carcinogenesis 20071101

Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue.

International journal of urology : official journal of the Japanese Urological Association 20070801

Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols.

Molecular cancer therapeutics 20070701

A phyllodes tumor of the urinary bladder in a rat.

Experimental oncology 20070601

Promotion of bladder cancer development and progression by androgen receptor signals.

Journal of the National Cancer Institute 20070404

Gene expression profiling of chemically induced rat bladder tumors.

Neoplasia (New York, N.Y.) 20070301

Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.

Oncology reports 20070201

DNA study of bladder papillary tumours chemically induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in Fisher rats.

International journal of experimental pathology 20070201

Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.

BMC cancer 20070101

The H19 non-coding RNA is essential for human tumor growth.

PloS one 20070101

Chemopreventive property of dietary ginger in rat urinary bladder chemical carcinogenesis.

World journal of urology 20061101

Effects of ginger (Zingiber officinale Roscoe) on DNA damage and development of urothelial tumors in a mouse bladder carcinogenesis model.

Environmental and molecular mutagenesis 20061001

Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients.

Cancer research 20060901

E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.

Journal of experimental & clinical cancer research : CR 20060901

Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of Nifurtimox, an antitrypanosomiasis drug.

Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20060701

Chemically induced bladder cancer--a sonographic and morphologic description.

Urology 20060701

[Development of invasive urinary bladder carcinomas].

Hinyokika kiyo. Acta urologica Japonica 20060601

Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran.

Oncology reports 20060301

Chemopreventive effects of cyclooxygenase-2 inhibitor and epidermal growth factor-receptor kinase inhibitor on rat urinary bladder carcinogenesis.

BJU international 20060301

Cytokeratin-20 and seminal vesicle secretory protein VI as possible marker proteins in urinary bladder preneoplastic lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.

International journal of urology : official journal of the Japanese Urological Association 20060201

Inhibition of rat urinary bladder carcinogenesis by the antiangiogenic drug TNP-470.

Asian Pacific journal of cancer prevention : APJCP 20060101

DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin.

Anticancer research 20060101

Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.

Journal of experimental & clinical cancer research : CR 20051201

Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.

International journal of cancer 20051120

Differences in susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis.

Cancer science 20051001

Tumour-suppression activity of the proapoptotic regulator Par4.

EMBO reports 20050601

A survivin gene signature predicts aggressive tumor behavior.

Cancer research 20050501

4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.

Carcinogenesis 20050301

Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.

Molecular carcinogenesis 20050301

Inhibition of tumor angiogenesis during cisplatin chemotherapy for bladder cancer improves treatment outcome.

Urology 20050201

Inactivation of the FHIT gene favors bladder cancer development.

Clinical cancer research : an official journal of the American Association for Cancer Research 20041115

Gene expression in the bladder carcinoma rat model.

Molecular carcinogenesis 20041001

Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.

Cancer research 20040915

Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine.

Neoplasia (New York, N.Y.) 20040901

Mitochondrial DNA mutations in chemical carcinogen-induced rat bladder and human bladder cancer.

Oncology reports 20040801

[Toxicological significance of metallothionein on environmental harmful factors: verification and suggestions from a metallothionein-I/II null mouse model study].

Nihon eiseigaku zasshi. Japanese journal of hygiene 20040701

Revised rat multi-organ carcinogenesis bioassay for whole-body detection of chemopreventive agents: modifying potential of S-methylcysteine.

Cancer letters 20040331

Accelerated induction of bladder cancer in patched heterozygous mutant mice.

Cancer research 20040315

Chemically induced immunotoxicity in a medium-term multiorgan bioassay for carcinogenesis with Wistar rats.

Toxicology and applied pharmacology 20040115

Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice.

Anticancer research 20040101

Is embryo-cryopreservation really neutral? A new long-term effect of embryo freezing in mice: protection of adults from induced cancer according to strain and sex.

Reproductive toxicology (Elmsford, N.Y.) 20040101

Infiltrating CD8+ T lymphocytes, natural killer cells, and expression of IL-10 and TGF-beta1 in chemically induced neoplasms in male Wistar rats.

Toxicologic pathology 20040101

Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N-butyl-N-(4-hydroxybutyl)-nitrosamine.

Cancer science 20031201

Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.

Cancer science 20031101

Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.

Aktuelle Urologie 20030701

Inhibitory effects of 2-mercaptoethane sulfonate and 6-phenylhexyl isothiocyanate on urinary bladder tumorigenesis in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Cancer letters 20030410

Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves.

International journal of urology : official journal of the Japanese Urological Association 20030301

Massive apoptotic cell death in chemically induced rat urinary bladder carcinomas following in situ HSVtk electrogene transfer.

The journal of gene medicine 20030301

Chemoprevention of lung carcinogenesis by cacao liquor proanthocyanidins in a male rat multi-organ carcinogenesis model.

Cancer letters 20030227

Inhibitory effect of clotrimazole on angiogenesis associated with bladder epithelium proliferation in rats.

International journal of urology : official journal of the Japanese Urological Association 20030201

No inhibition of urinary bladder carcinogenesis in rats with intravesical instillation of alpha-galactosylceramide.

Asian Pacific journal of cancer prevention : APJCP 20030101

Distinction of carcinogens from mutagens by induction of liver cell foci in a model for detection of initiation activity.

Cancer letters 20021215

Effects of antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone or ascorbic acid on carcinogenesis induced by administration of aminopyrine and sodium nitrite in a rat multi-organ carcinogenesis model.

Japanese journal of cancer research : Gann 20021201

Influence of pertussis toxin on superficial bladder carcinoma in rats.

Urological research 20020701

Telomerase is upregulated in irreversible preneoplastic lesions during bladder carcinogenesis in rats.

Japanese journal of cancer research : Gann 20020501

Lack of enhancing effect of two Kampo medicines, Sho-saiko-to (TJ-9) and Sairei-to (TJ-114), on rat urinary bladder carcinogenesis initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.

Teratogenesis, carcinogenesis, and mutagenesis 20020101

Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.

Japanese journal of cancer research : Gann 20020101

Promoting the effects of intravesical instillation of saline on bladder lesion development in rats pre-treated with BBN.

International journal of urology : official journal of the Japanese Urological Association 20020101

Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Nutrition and cancer 20020101

[Use of Azopiram for rapid diagnosis of epithelial tumors of the urinary bladder (experimental data)].

Voprosy onkologii 20020101

p53 and H-ras mutations and microsatellite instability in renal pelvic carcinomas of NON / Shi mice treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine: different genetic alteration from urinary bladder carcinoma.

Japanese journal of cancer research : Gann 20011201

Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model.

Japanese journal of cancer research : Gann 20011101

[Study on different responses of rats' small intestine mucous membrane and bladder transitional epithelium in the same carcinogenic urine environment].

Zhonghua yi xue za zhi 20011025

Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.

Cancer research 20011001

Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of moxifloxacin, a quinolone antibiotic.

Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20011001

Lack of change in the levels of liver and kidney cytochrome P-450 isozymes in p53+/- knockout mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.

Mutagenesis 20010901

Site-dependent modulating effects of conjugated fatty acids from safflower oil in a rat two-stage carcinogenesis model in female Sprague-Dawley rats.

Cancer letters 20010710

Possible involvement of O6-methylguanine formation and p53 dysfunction in mouse urinary bladder carcinogenesis.

Mutation research 20010602

The effects of organ resection on rat urinary bladder carcinogenesis.

Urological research 20010601

Inhibitory effect of peptide vilon on the development of induced rat urinary bladder tumors in rats.

Bulletin of experimental biology and medicine 20010601

Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.

Cancer research 20010515

Suicide gene therapy for chemically induced rat bladder tumor entailing instillation of adenoviral vectors.

Japanese journal of cancer research : Gann 20010501

Preferential gene transfer to BBN-induced rat bladder tumor by simple instillation of adenoviral vector.

Urology 20010301

[Effect of vilon and epithalone on induction and growth of induced bladder neoplasms in rats].

Voprosy onkologii 20010101

Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis.

Nutrition and cancer 20010101

Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity.

Cancer letters 19990524

Natural killer activity in a medium-term multi-organ bioassay for carcinogenesis.

Japanese journal of cancer research : Gann 19990101

[Effects of androgen regulation system on bladder carcinogenesis in male mice].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 19951101

Increased gap junctional intercellular communication capacity and connexin 43 and 26 expression in rat bladder carcinogenesis.

Carcinogenesis 19941001

Modifying effects of various chemicals on tumor development in a rat wide-spectrum organ carcinogenesis model.

Japanese journal of cancer research : Gann 19920801

[The lithium carbonate promotion of urothelial tumors in rats induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine].

Voprosy onkologii 19920101

Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Japanese journal of cancer research : Gann 19911101

Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats.

Cancer research 19910401

Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Japanese journal of cancer research : Gann 19901201

Structure-activity relations in promotion of rat urinary bladder carcinogenesis by phenolic antioxidants.

Japanese journal of cancer research : Gann 19900801

Correlation between medium-term liver bioassay system data and results of long-term testing in rats.

Carcinogenesis 19900401

Activating missense mutations in Ha-ras-1 genes in a malignant subset of bladder lesions induced by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-[4-(5-nitro-2-furanyl)-2-thiazolyl]formamide.

Molecular carcinogenesis 19900101

Effects of sodium salts of phenobarbital and barbital on development of bladder tumors in male F344/NCr rats pretreated with either N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-nitrosobutyl-4-hydroxybutylamine.

Toxicology and applied pharmacology 19890401

Chromosomal characteristics and malignancy of urothelial cells from carcinogen-treated rats.

Journal of the National Cancer Institute 19890301

Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.

Cancer letters 19870101

Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Cancer letters 19860801

[Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].

Der Urologe. Ausg. A 19840901

Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.

IARC scientific publications 19840101

Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 19830201

Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.

Carcinogenesis 19830101

Modification of chemical carcinogenesis by antioxidants.

Princess Takamatsu symposia 19830101

Effect of partial cystectomy on the induction of pre-neoplastic lesions in rat bladder initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by bladder carcinogens and promoters.

Urological research 19820101

Maintenance by saccharin of membrane alterations of rat bladder cells induced by subcarcinogenic treatment with bladder carcinogens.

Cancer research 19811101

Inhibitory effect of 4,4'-diaminodiphenylmethane on liver, kidney and bladder carcinogenesis in rats ingesting N-ethyl-N-hydroxyethylnitrosamine or N-butyl-N-(4-hydroxybutyl) nitros-amine.

Carcinogenesis 19810101

Induction of hyperplastic liver nodules by phenobarbital in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.

Gan 19801201

Effect of cyclophosphamide on rat urinary bladder epithelium treated wtih N-butyl-N-(4-hydroxybutyl)nitrosamine.

Gan 19801001

Effects of sodium saccharin and caffeine on the urinary bladder of rats treated with n-butyl-n-(4-hydroxybutyl)nitrosamine.

Gan 19800801